Header graphic for print
The Healthcare Investor Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses

Tag Archives: contract

Private Equity Opportunities in Contract Research Organizations (CROs): Part II

Posted in Healthcare Services Investing

In Part II of this blog series we look at recent transactions in the arena of contract research organization, with a particular focus on private equity investing in CROs. In one recent example, prescription drug data-mining company IMS Health acquired TTC, Philadelphia, a drug trials data-analytics company for drug manufacturers and drug contract research organizations… Continue Reading

Private Equity Opportunities in Contract Research Organizations (CROs): Part I

Posted in Healthcare Services Investing

Contract research organizations (CRO) provide research services support for the biotechnology, medical device and pharmaceutical industries on a contractual basis. They offer such services as preclinical and clinical research, clinical trials management, biopharmaceutical development and pharmacovigilance. CROs run the gamut from international full-service organizations to niche specialty businesses. The emergence of the strategic partnership model,… Continue Reading

Contract Research Organizations (CROs) Go Private; Another Segment of Opportunity for Investors?

Posted in Healthcare Services Investing

PPD/Pharmaceutical Product Development, an international contract research firm that has just been named to the 2011 InformationWeek 500, is being taken private by affiliates of the Carlyle Group and Hellman & Friedman in a cash deal valued at $3.9 billion. The two PE firms have reportedly paid $33.25/share for PPD, a 29.6% premium over its… Continue Reading